A drug used to treat type 2 diabetes has been found to lower the risk of dementia by more than one third, according to a new study. Published in the BMJ, the research suggests that the medicine, called sodium-glucose cotransporter-2 (SGLT-2) inhibitors, may lower the risk of dementia by 35%. According to the NHS, there…
